Cathepsin D expression is decreased in Alzheimer's disease fibroblasts

Neurobiology of Aging

Volumn 29, Issue 1, 2008, Pages 12-22

  Urbanelli, Lorena ^a   Emiliani, Carla ^a   Massini, Carlo ^a   Persichetti, Emanuele ^a   Orlacchio, Antonio ^b,c   Pelicci, Giuliana ^d   Sorbi, Sandro ^e   Hasilik, Andrej ^f   Bernardi, Giorgio ^b,c   Orlacchio, Aldo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Alzheimer's disease; Cathepsin D; Gene expression; Peripheral markers

Indexed keywords

CATHEPSIN D; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL LYSATE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROBLAST; FLUOROMETRY; FRONTAL CORTEX; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYSOSOME; MALE; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ADULT; ALZHEIMER DISEASE; CATHEPSIN D; CELLS, CULTURED; DOWN-REGULATION; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; FLAVONOIDS; HUMANS; MALE; MIDDLE AGED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 36048971629     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.09.005     Document Type: Article

References (49)

1. Adamec E., Mohan P.S., Cataldo A.M., Vonsattel J.P., and Nixon R.A. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience 100 3 (2000) 663-675
2. Bahr B.A., and Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83 (2002) 481-489 [Review]
3. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17 (1996) 1005-1013
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
5. Cataldo A.M., and Nixon R.A. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci USA 87 10 (1990) 3861-3865
6. Cataldo A.M., Paskevich P.A., Kominami E., and Nixon R.A. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci USA 88 24 (1991) 10998-11002
7. Cataldo A.M., Barnett J.L., Berman S.A., Li J., Quarless S., Bursztajn S., et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14 3 (1995) 671-680
8. Cecchi C., Fiorillo C., Sorbi S., Latorraca S., Nacmias B., Bagnoli S., et al. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic Biol Med 33 10 (2002) 1372-1379
9. Citron M., Vigo-Pelfrey C., Teplow D.B., Miller C., Schenk D., Johnston J., et al. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci USA 91 25 (1994) 11993-11997
10. Connolly G.P. Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol Sci 19 5 (1998) 171-177
11. Deiss L.P., Galinka H., Berissi H., Cohen O., and Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-α. EMBO J 15 (1996) 3861-3870
12. Demoz M., Castino R., Dragonetti A., Raitieri E., Baccino F.M., and Isidoro C. Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. J Cell Biochem 73 (1999) 370-378
13. Demoz M., Castino R., Follo C., Hasilik A., Sloane B.F., and Isidoro C. High yield synthesis and characterization of phosphorylated recombinant human procathepsin D expressed in mammalian cells. Protein Expr Purif 45 1 (2006) 157-167
14. Diment S., Martin K.J., and Stahl P.D. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem 264 23 (1989) 13403-13406
15. Dreyer R.N., Bausch K.M., Fracasso P., Hammond L.J., Wunderlich D., Wirak D.O., et al. Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. Eur J Biochem 224 2 (1994) 265-271
16. Emiliani C., Urbanelli L., Racanicchi L., Orlacchio A., Pelicci G., Sorbi S., et al. Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation. J Biol Chem 278 40 (2003) 38453-38460
17. Evin G., Cappai R., Li Q.X., Culvenor J.G., Small D.H., Beyreuther K., et al. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D. Biochemistry 34 43 (1995) 14185-14192
18. Fruitier I., Garreau I., and Piot J.M. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7. Biochem Biophys Res Commun 246 3 (1998) 719-724
19. Gandy S., and Petanceska S. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Biochim Biophys Acta 1502 (2000) 44-52 [Review]
20. Gartner U., Holzer M., and Arendt T. Induction of p21ras in Alzheimer pathology. Neuroreport 6 (1995) 1441-1444
21. Gartner U., Holzer M., and Arendt T. Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience 91 (1999) 1-5
22. Gruninger-Leitch F., Berndt P., Langen H., Nelboeck P., and Dobeli H. Identification of beta-secretase-like activity using a mass spectrometry-based assay system. Nat Biotechnol 18 1 (2000) 66-70
23. Isidoro C., Demoz M., De Stefanis D., Baccino F.M., Hasilik A., and Bonelli G. Differential targeting and processing of procathepsin D in normal and transformed murine 3T3 fibroblasts. Int J Cancer 70 3 (1997) 310-314
24. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 5580 (2002) 353-356 [Review]
25. Hazzalin C.A., Cuenda A., Cano E., Cohen P., and Mahadevan L.C. Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli. Oncogene 15 19 (1997) 2321-2331
26. Higaki J., Catalano R., Guzzetta A.W., Quon D., Nave J.F., Tarnus C., et al. Processing of beta-amyloid precursor protein by cathepsin D. J Biol Chem 271 50 (1996) 31885-31893
27. Hofmann S.L., and Peltonen L. The neuronal ceroid lipofuscinoses. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 8th ed. (2001), McGraw-Hill, New York 3877-3894
28. Hussain I., Powell D., Howlett D.R., Tew D.G., Meek T.D., Chapman C., et al. Identification of a novel aspartic protease (Asp2) as beta-secretase. Mol Cell Neurosci 14 6 (1999) 419-427
29. Kagedal K., Johansson U., and Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15 (2001) 1592-1594
30. Kenessey A., Nacharaju P., Ko L.W., and Yen S.H. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem 69 5 (1997) 2026-2038
31. Kalmes A., Deou J., Clowes A.W., and Daum G. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580. FEBS Lett 444 1 (1999) 71-74
32. Kohnken R.E., Ladror U.S., Wang G.T., Holzman T.F., Miller B.E., and Krafft G.A. Cathepsin D from Alzheimer's-diseased and normal brains. Exp Neurol 133 2 (1995) 105-112
33. Koike M., Nakanishi H., Saftig P., Ezaki J., Isahara K., Ohsawa Y., et al. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20 (2000) 6898-6906
34. Lai M.T., Crouthamel M.C., DiMuzio J., Pietrak B.L., Donoviel D.B., Bernstein A., et al. A presenilin-independent aspartyl protease prefers the gamma-42 site cleavage. J Neurochem 96 January (1) (2006) 118-125 [Epub 2005 Nov 21]
35. McKhann G., Drachman G., and Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the department of health and human services task force on Alzheimer's disease. Neurology 34 (1984) 939-944
36. Nakanishi H. Neuronal and microglial cathepsins in aging and age-related diseases. Aging Res Rev 2 4 (2003) 367-381
37. Partanen S., Storch S., Loffler H.G., Hasilik A., Tyynela J., and Braulke T. A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells. Biochem J 369 (2003) 55-62
38. Pearson M., Carbone R., Sebastiani C., Cioce M., Fagioli M., Saito S., et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406 6792 (2000) 207-210
39. Rijnboutt S., Kal A.J., Geuze H.J., Aerts H., and Strous G.J. Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells. J Biol Chem 266 (1991) 23586-23592
40. Saftig P., Hetman M., Schmahl W., Weber K., Heine L., Mossmann H., et al. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 14 (1995) 3599-3608
41. Saftig P., Peters C., von Figura K., Craessaerts K., Van Leuven F., and De Strooper B. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem 271 44 (1996) 27241-27244
42. Schwagerl A.L., Mohan P.S., Cataldo A.M., Vonsattel J.P., Kowall N.W., and Nixon R.A. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J Neurochem 64 1 (1995) 443-446
43. Sisodia S.S., and St George-Hyslop P.H. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?. Nat Rev Neurosci 3 4 (2002) 281-290 [Review]
44. Straface E., Matarrese P., Gambardella L., Vona R., Sgadari A., Silveri M.C., et al. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett 579 (2005) 2759-2766
45. Tyynela J., Sohar I., Sleat D.E., Gin R.M., Donnelly R.J., Baumann M., et al. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J 19 (2000) 2786-2792
46. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 5440 (1999) 735-741
47. Wolf M., Clark-Lewis I., Buri C., Langen H., Lis M., and Mazzucchelli L. Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. Am J Pathol 162 4 (2003) 1183-1190
48. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., and Selkoe D.J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398 6727 (1999) 513-517
49. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., et al. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402 6761 (1999) 533-537